ORGS
Orgenesis Inc

836
Mkt Cap
$4.13M
Volume
100.00
52W High
$5.89
52W Low
$0.0001
PE Ratio
-0.09
ORGS Fundamentals
Price
$0.7999
Prev Close
$0.7999
Open
$0.7999
50D MA
$0.4523
Beta
502.92
Avg. Volume
1,212.30
P/B
-0.16
Loading...
Loading...
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point of care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Orgenesis Inc?
What is the 52-week high for Orgenesis Inc?
What is the 52-week low for Orgenesis Inc?
What is Orgenesis Inc stock price today?
What was Orgenesis Inc stock price yesterday?
What is the PE ratio of Orgenesis Inc?
What is the Price-to-Book ratio of Orgenesis Inc?
What is the 50-day moving average of Orgenesis Inc?

Latest ORGS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.